ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

October 8, 2010

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993

November 8, 1991